Evaluation of Intact Fibroblast Growth Factor 23 (FGF-23) as Predictors of Bone Integrity in Patients with Chronic Kidney Disease

Authors

  • Huseein mohammed kadhim Medical Laboratory Technique Dept., College of Health & Medical Technique, Southern Technical University, Basrah, Iraq Author
  • Dawood S. Mahdi Medical Laboratory Technique Dept., College of Health & Medical Technique, Southern Technical University, Basrah, Iraq Author
  • Hamid Jaddoa Abbas Al-Faiha’a Teaching Hospital, Al- Zehra ’a Medical College, University of Basra, Basra, Iraq. Author

Keywords:

CKD, bone disease, fibroblast growth factor- 23, FGF- 23, vitamin D, bone ALP.

Abstract

Chronic kidney disease is an international public health problem affecting 5—10% of the world population. Newly discovered humoral factors- fibroblast growth factor -23 (FGF-23), that are involved in phosphate and vitamin D homeostasis. Elevated levels of the phosphate-regulating hormone fibroblast growth factor- 23 have been linked to greater risk of fractures, especially among individuals with chronic kidney disease (CKD). Therefore, this study was aimed to evaluate FGF23 as a predictor for bone loss and fractures in patients with chronic kidney disease.  A case control study; involved (184) participates: 129 patients that meet inclusion criteria and 55 healthy individuals as control group. Serum intact FGF-23 level was measured using an enzyme-linked immunosorbent assay kit. Immune assay (Roche Cobas E411) and spectrophotometry (Roche Cobas C311) techniques were used to analysis other parameters.  The current study showed significant differences (p< 0.05) in the BMI (26.8), uric acid (4.34), urea (28.18), creatinine (0.76), phosphorus (3.42), calcium (9.12), vitamin D (31.55), albumin (4.30), alkaline phosphatase (74.49), bone specific alkaline phosphatase (1.83), parathyroid hormone (33.51), GFR (88.15) and intact FGF- 23 (133.3) of control group in comparison with BMI (24.1), uric acid (6.53), urea (139.4), creatinine (7.69), phosphorus (6.309), calcium (8.813), vitamin D (15.14), albumin (3.79), alkaline phosphatase (120.2), bone specific alkaline phosphatase (11.85), parathyroid hormone (153.7), GFR (19.47) and intact FGF- 23 (390.1) of CKD patients; respectively. The results of this study were shown no significant differences between CKD patients and healthy control, regarding to ages (P =0.07) and gender (P =0.629). Whereas, showed significant decreases of vitamin D, albumin, calcium levels inpatients, when compared to the control group. 

Downloads

Download data is not yet available.

References

Agoro, Rafiou, Pu Ni, Megan L. Noonan, and Kenneth E.

White. 2020. "Osteocytic FGF23 and Its Kidney

Function." Frontiers in Endocrinology 11:592.

Ammirati, Adriano Luiz. 2020. "Chronic Kidney Disease."

Revista Da Associated© Medico Brasileira 66:s03-9.

Hafez, Eman Ahmed, Sameh Abd El-mottleb Hassan,

Mohammed Abdel Monem Teama, and Fatma

Mohammed Badr. 2021. "Serum Uric Acid as a Predictor

for Nephritis in Egyptian Patients with Systemic Lupus

Erythematosus." Lupus 30(3):378-84.

Haffner, Dieter, Francesco Emma, Deborah M. Eastwood,

Martin Biosse Duplan, Justine Bacchetta, Dirk Schnabel,

Philippe Wicart, Detlef Bockenhauer, Fernando Santos,

and Elena Levtchenko. 2019. "Clinical Practice

Recommendations for the Diagnosis and Management

of X-Linked Hypophospha taemia." Nature Reviews

Nephrology 15(7):435-55.

Hameed Mohamed, Shakir, Ahmed Methab Athab, Nabeel

Khalid mohammed Ali, and Ismail Ibrahim Latif. 2019.

"Mineral Derangement and Bone Diseases in Uremic

Patients on Hemodialysis in Ibn-Sina Hemodialysis

Center/Diyala." Diyala Journal of Medicine 17(1):60-76.

Haussler, Mark R., Sarah Livingston, Zhela L. Sabir, Carol A.

Haussler, and Peter W. Jurutka. 2021. "Vitamin D

Receptor Mediates a Myriad of Biological Actions

Dependent on Its 1, 25 dihydroxyvitamin D Ligand:

Distinct Regulatory Themes Revealed by Induction of

Klotho and Fibroblast Growth Factor 23. JBMR Plus

Silva, Fernando Remiao, Luciano Saso, Katerina MaldLddovd, and Josef Maly. 2022. "Vitamin D: Sources,

Physiological Role, Biokinetics, Deficiency, Therapeutic

Use, Toxicity, and Overview of Analytical Methods for

Detection of Vitamin D and Its Metabolites." Critical

Reviews in Clinical Laboratory Sciences 59(8):517-54.

Isakova, T. et al. (2011) 'Fibroblast growth factor 23 and

risks of mortality and end-stage renal disease in

patients with chronic kidney disease', Jama, 305(23),

pp. 2432-2439.

Kameda, Tomohito, Kazuya Horikoshi, Shogo Kumagai,

Yuko Saito, and Toshiaki Yoshioka. 2020. "Adsorption of

Urea, Creatinine, and Uric Acid onto Spherical Activated

Carbon." Separation and Purification Technology

:116367.

Kawarazaki, Hiroo, Yugo Shibagaki, Seiji Fukumoto, Ryo

Kido, Katsuyuki Ando, Ichiro Nakajima, Shohei

Fuchinoue, Toshiro Fujita, Masafumi Fukagawa, and

Satoshi Teraoka. 2011. "Natural History of Mineral and

Bone Disorders After Living Donor Kidney

Transplantation: A One Year Prospective Observational

Study. Therapeutic Apheresis and Dialysis15(5):481-87.

Koppe, Laetitia, Denis Fouque, and Kamyar Kalantar

Zadeh. 2019. Kidney Cachexia or Protein energy

Wasting in Chronic Kidney Disease: Facts and

Numbers. Journal of Cachexia, Sarcopenia and Muscle

(3):479-84.

Luft, Friedrich C. 2021. "Biomarkers and Predicting Acute

Kidney Injury." Acta Physiologica 231(1):e13479.

Mace, Maria L., Klaus Olgaard, and Ewa Lewin. 2020. "New

Aspects of the Kidney in the Regulation of Fibroblast

Growth Factor 23 (Fgf23) and Mineral Homeostasis."

International Journal of Molecular Sciences 21(22):1-2O.

Nonso, C. A., C. I. Sam, B. A. Ejikeme, A. Aliyu, and D. O.

Ifeyinwa. 2019. "Responses of Urea, Creatinine and Uric

Acid to Soft Tissue and Passive Mobilization in Patients

with Renal Diseases Undergoing Haemodialysis." J

Nephrol Ther 9(326):959-2161.

Nizet, A. et al. (2020) 'Bone alkaline phosphatase: An

important biomarker in chronic kidney disease-mineral

and bone disorder', Clinica Chimica Acta, 501, pp. 198-

Staykova, Sv, Ya Bocheva, and K. Prodanova. 2018.

"Comparison of Specific Bone Biomarkers in Chronic

Kidney Disease Bulgarian Patients with Secondary

Hyperparathy roidism." IOSR J. Dental Med. Sci 17:85-

Wally, Riyadh Hussein. 2016. "Effects of Chronic Kidney

Disease on Some Liver Enzymes Activity Before and

After Dialysis." Journal of the College of Basic

Education 22(96):89-94.

Wolf, M. (2012) 'Update on fibroblast growth factor 23 in chronic kidney disease', Kidney international, 82(7), pp. 737-747.

Downloads

Published

2023-04-30

Issue

Section

Articles

How to Cite

mohammed kadhim, H., S. Mahdi, D., & Jaddoa Abbas, H. (2023). Evaluation of Intact Fibroblast Growth Factor 23 (FGF-23) as Predictors of Bone Integrity in Patients with Chronic Kidney Disease. History of Medicine, 9(2). https://historymedjournal.com/HOM/index.php/medicine/article/view/526